Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
Trump Says Anthropic No Longer Seen as National Security Threat 
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
Carro Expands Into Australia With Acquisition of Used-Car Platform CarPlace 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
BHP Shares Fall as Jansen Potash Project Costs Surge 
LOUISVILLE, Ky., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the state of Vermont has adopted Appriss' Prescription Drug Monitoring Solution to improve patient safety and help deter prescription drug abuse and drug diversion.
Prescription Monitoring Programs (PMPs) are state-run programs that track the distribution of narcotics and other prescriptions for federally controlled substances. Appriss's PMP platform provides access to mandatory pharmacy reporting and offers secure accessibility to data across state lines.
"Appriss is committed to ensuring patient safety," says Krishnan Sastry, Executive Vice President of Appriss, Inc. "Appriss's solution will support providers and dispensers in Vermont to ensure better prescribing decisions and help state administrators analyze patterns of consumption to drive patient safety and health policy."
Vermont implemented the PMP platform in October and joins 23 other states in choosing Appriss' PMP Solution to address prescription drug abuse and diversion.
About Appriss
Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed. Partnering with public safety, healthcare, and leading private and public companies, Appriss delivers solutions that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives. Appriss' solutions are always backed by excellent customer support with technical agents in the US that are available to help 24x7x365.
For more information, visit www.appriss.com (http://www.appriss.com).
CONTACT: Kathy Sue Bennett
Marketing Manager
[email protected]
